On-demand transarterial chemoembolisation combined with atezolizumab and bevacizumab in patients with untreated hepatocellular carcinoma (TALENTACE): a multicentre, randomised, open-label, phase 3 trial
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-09-15 17:03:47 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s2468-1253(26)00212-8
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2468125326002128
其他信息:
出版社: Elsevier BV
作者: Masatoshi Kudo; Sadahisa Ogasawara; Ruibao Liu; Shanzhi Gu; Kunyuan Wang; Ming Zhao; Hongtao Hu; Zhaoyu Liu; Kecan Lin; Jingfeng Liu; Zhengyu Lin; Yonghong Zhang; Tao Peng; Jinhua Song; Makoto Ueno; Jiye Zhu; Lidan Bai; Lin Tong; Yanjun Shi; Guohong Han; Jiahong Dong

